Generate a tailored SOP for Dr. Samuel Wilkinson. Improve your application with a focused, well-structured draft.
Samuel Wilkinson, MD, is an Associate Professor at Yale School of Medicine, specializing in Psychiatry. His research interests focus on improving access to and the dissemination of evidence-based therapies for depression and mood disorders. He is particularly engaged in developing strategies for relapse prevention in severe treatment-resistant depression, utilizing electroconvulsive therapy (ECT) as a central theme of his work. Additionally, he explores the effects of intravenous ketamine on severe depression, emphasizing the potential of cognitive behavioral therapy as a complementary approach. He has a keen interest in the evolving legal status of cannabis and its approved use in managing conditions like posttraumatic stress disorder (PTSD), contributing to discussions on the safety and efficacy of cannabis-based treatments. His endeavors aim to enhance clinical outcomes through patient-centered research and collaborations with stakeholders.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.